Published in Br Med J on September 17, 1966
Synergism between respiratory viruses and bacteria. Yale J Biol Med (1968) 1.83
Rhinoviruses. Yale J Biol Med (1975) 1.66
Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. BMJ (1996) 1.60
The antiviral activity of the isoquinolines famotine and memotine in respiratory infections in man. Bull World Health Organ (1969) 0.80
Infectious diseases. Annual review of significant publications. Postgrad Med J (1967) 0.75
The role of viral infection in the etiology and pathogenesis of chronic bronchitis and emphysema, with consideration of a naturally occurring animal model. Yale J Biol Med (1968) 0.75
The immunogenicity of the intradermal injection of seasonal trivalent influenza vaccine containing influenza A(H1N1)pdm09 in COPD patients soon after a pandemic. Hum Vaccin Immunother (2016) 0.75
The factor of infection in chronic bronchitis. Q J Med (1953) 4.47
Principles of definition in medicine with special reference to chronic bronchitis and emphysema. Lancet (1959) 3.50
A VIROLOGIC STUDY OF CHRONIC BRONCHITIS. N Engl J Med (1964) 2.28
PROBLEMS OF LABORATORY DIAGNOSIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDHOOD. Arch Gesamte Virusforsch (1964) 2.15
RESPIRATORY SYNCYTIAL VIRUS IN ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS. Lancet (1963) 2.06
INFECTION WITH INFLUENZA AND PARAINFLUENZA VIRUSES IN CRONIC BRONCHITIS. Thorax (1965) 1.40
PRODUCTION OF TRACHEOBRONCHITIS IN VOLUNTEERS WITH RHINOVIRUS IN A SMALL-PARTICLE AEROSOL. Am J Epidemiol (1965) 1.37
Virus studies in chronic bronchitis. Am Rev Respir Dis (1960) 1.28
An attempt to demonstrate a viral etiology for chronic bronchitis. Am Rev Respir Dis (1962) 0.98
Anti-cell antibody in macaques. Nature (1991) 5.56
New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet (1971) 5.41
Hepatitis in clinical laboratories 1973-74. J Clin Pathol (1976) 4.27
Hepatitis in clinical laboratories: a three-year survey. J Clin Pathol (1975) 3.68
Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet (1995) 3.47
Hazards in the clinical pathology laboratory. Proc R Soc Med (1973) 3.38
Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology (1984) 3.27
Enteroviruses in human disease. Prog Med Virol (1978) 3.18
A six-year study of coxsackievirus B infections in heart disease. J Hyg (Lond) (1974) 3.12
Influenza, respiratory syncytial virus, and pneumonia in Glasgow, 1962-5. Br Med J (1967) 2.76
A cumulative review of studies on travellers, their experience of illness and the implications of these findings. J Infect (1990) 2.50
Infections in British clinical laboratories 1980-81. J Clin Pathol (1983) 2.38
Respiratory syncytial virus. Brief review. Arch Virol (1985) 2.31
Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge. J Virol (1986) 2.18
Hepatitis in clinical laboratories 1975-76. J Clin Pathol (1978) 2.17
Respiratory syncytial virus infection in mice. Infect Immun (1984) 2.14
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
Further studies of enterovirus infections in cardiac disease and pleurodynia. Scand J Infect Dis (1970) 2.03
Letter: "High isolation" accommodation for infectious diseases. Lancet (1973) 2.02
Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology (1987) 2.02
Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. J Virol (1987) 1.98
Hepatitis and other infections in clinical laboratory staff, 1979. J Clin Pathol (1981) 1.96
Infection and travel: the experience of package tourists and other travellers. J Infect (1980) 1.95
The detection of respiratory syncytial virus in nasopharyngeal aspirates: assessment, formulation, and evaluation of monoclonal antibodies as a diagnostic reagent. J Med Virol (1986) 1.93
Poliomyelitis: A gap in immunity? Lancet (1973) 1.93
Rhinoviruses. Annu Rev Microbiol (1972) 1.90
Viruses and myocarditis. Postgrad Med J (1972) 1.84
Infections in British clinical laboratories, 1982-3. J Clin Pathol (1985) 1.82
Hepatitis infection in clinical laboratory staff. Med Lab Sci (1981) 1.78
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol (1992) 1.73
Viral contamination of bovine foetal serum and cell cultures. Nature (1977) 1.65
Immune electron microscopy of rhinoviruses. J Virol (1972) 1.64
Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. J Gen Virol (1997) 1.62
Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res Hum Retroviruses (1992) 1.60
Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. J Gen Virol (1985) 1.52
A survey of virus infections of the respiratory tract of cattle and their association with disease. J Hyg (Lond) (1980) 1.49
Illness associated with "package tours": a combined Spanish-Scottish study. Bull World Health Organ (1978) 1.47
Echoviruses, carditis, and acute pleurodynia. Lancet (1970) 1.43
Letter: Parenteral versus non-parenteral transmission of viral hepatitis B. Lancet (1974) 1.39
Human AIDS and rabbit myxomatosis. J Infect (1988) 1.39
Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS (1991) 1.39
Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice. J Virol (1987) 1.38
Factors affecting the growth of Rhinovirus 2 in suspension cultures of L132 cells. J Gen Virol (1970) 1.38
Rhinovirus infections in chronic bronchitis: isolation of eight possibly new rhinovirus serotypes. J Med Microbiol (1968) 1.37
Infective agents and chronic bronchitis. Thorax (1966) 1.36
Coxsackie viruses and the heart. Am Heart J (1969) 1.32
Letter: Psittacosis and surveillance. Lancet (1974) 1.30
A comparison of three vaccines against respiratory syncytial virus in calves. J Hyg (Lond) (1984) 1.27
Hepatitis in clinical laboratories 1977-78. J Clin Pathol (1980) 1.26
Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity. J Virol (1994) 1.25
Identification of rhinovirus stran D.C. Nature (1968) 1.24
Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland. Rev Infect Dis (1984) 1.22
Coxsackie virus infections in patients with acute cardiac disease and chest pain. Scott Med J (1968) 1.22
Letter: A survey of hepatitis in laboratories. J Clin Pathol (1974) 1.21
Letter: Samples for hepatitis B antigen testing. Br Med J (1974) 1.21
Human abortion associated with infection by ovine abortion agent. Br Med J (1967) 1.21
Safety of poliomyelitis vaccines. Br Med J (Clin Res Ed) (1983) 1.21
Molecular weight of rhinovirus ribonucleic acid. J Gen Virol (1970) 1.17
Characterization of bovine respiratory syncytial virus proteins and mRNAs and generation of cDNA clones to the viral mRNAs. J Virol (1989) 1.17
Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies. J Gen Virol (1992) 1.14
Studies of respiratory viruses in personnel at an Antarctic base. J Hyg (Lond) (1971) 1.14
Pathological, rickettsiological and immunofluorescence studies of a case of Q fever endocarditis. J Pathol Bacteriol (1966) 1.12
A comparative virological study of children in hospital with respiratory and diarrhoeal illnesses. J Hyg (Lond) (1967) 1.12
Antigenic variation among strains of rhinovirus type 51. Nature (1969) 1.12
Acute viral infections of the nervous system. Proc R Soc Med (1967) 1.09
Virological studies of sudden, unexplained infant deaths in Glasgow 1967-70. J Clin Pathol (1972) 1.08
A reverse passive haemagglutination test for the detection of respiratory syncytial virus in nasal secretions from infants. J Med Virol (1981) 1.07
Rhinovirus infections of children in hospital; isolation of three possibly new rhinovirus serotypes. Am J Epidemiol (1969) 1.07
Studies of experimental rhinovirus type 2 infections in polar isolation and in England. J Hyg (Lond) (1976) 1.07
Psittacosis. Br Med J (1972) 1.07
Legionnaires' disease. Lancet (1977) 1.06
Experimentally produced calf pneumonia. Res Vet Sci (1976) 1.05
Coxsackie A-7 virus infections of rodents. Arch Gesamte Virusforsch (1966) 1.04
Epidemic keratoconjunctivitis. Br Med J (1971) 1.04
A search for new microorganisms in calf pneumonia by the inoculation of gnotobiotic calves. Res Vet Sci (1982) 1.04
Illness amongst travellers to Scotland: a pilot study. Health Bull (Edinb) (1983) 1.03
Histopathological changes in simian immunodeficiency virus infection. J Pathol (1990) 0.99
Pandemic influenza 1918. Br Med J (1980) 0.99
Cytotoxicity of alveolar macrophages for virus-infected cells. Nature (1975) 0.99
Rhinoviraemia. Br Med J (1970) 0.99
Evaluation of respiratory disease in calves: comparison of disease response to different viruses. Res Vet Sci (1977) 0.98
Legionnaires' disease and the traveller. Ann Intern Med (1979) 0.98
Travel and health: illness associated with winter package holidays. J R Coll Gen Pract (1983) 0.98
Protection against respiratory disease in calves induced by vaccines containing respiratory syncytial virus, parainfluenza type 3 virus, Mycoplasma bovis and M dispar. Vet Rec (1987) 0.97
Surveillance of hepatitis in laboratory staff: a seven year study. Med Microbiol Immunol (1978) 0.97
Coxsackie virus heart diseases. Br Med J (1968) 0.97
Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage. J Gen Virol (1992) 0.96
The effect of pneumonia induced in mice with Mycoplasma pulmonis on resistance to subsequent bacterial infection and the effect of a respiratory infection with Sendai virus on the resistance of mice to Mycoplasma pulmonis. J Gen Microbiol (1978) 0.96
Enteroviral etiology of the paralytic poliomyelitis syndrome. Arch Environ Health (1970) 0.95
The construction and evaluation of SIV/HIV chimeras that express the envelope of European HIV type 1 isolates. AIDS Res Hum Retroviruses (1997) 0.95
Role of Coxsackie B viruses in myocardial infarction. Br Heart J (1978) 0.95
Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity. J Immunol (1991) 0.94
Induction of pneumonia in gnotobiotic calves following inoculation of Mycoplasma dispar and ureaplasmas (T-mycoplasmas). Res Vet Sci (1976) 0.93